BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21956609)

  • 1. CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.
    Oliveira MI; Gonçalves CM; Pinto M; Fabre S; Santos AM; Lee SF; Castro MA; Nunes RJ; Barbosa RR; Parnes JR; Yu C; Davis SJ; Moreira A; Bismuth G; Carmo AM
    Eur J Immunol; 2012 Jan; 42(1):195-205. PubMed ID: 21956609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of CD6-mediated interactions in T cell activation and proliferation.
    Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
    J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
    Hassan NJ; Barclay AN; Brown MH
    Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
    Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
    J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
    Nair P; Melarkode R; Rajkumar D; Montero E
    Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation.
    Gonçalves CM; Henriques SN; Santos RF; Carmo AM
    Front Immunol; 2018; 9():2994. PubMed ID: 30619347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.
    Hassan NJ; Simmonds SJ; Clarkson NG; Hanrahan S; Puklavec MJ; Bomb M; Barclay AN; Brown MH
    Mol Cell Biol; 2006 Sep; 26(17):6727-38. PubMed ID: 16914752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T cell CD6 receptor operates a multitask signalosome with opposite functions in T cell activation.
    Mori D; Grégoire C; Voisinne G; Celis-Gutierrez J; Aussel R; Girard L; Camus M; Marcellin M; Argenty J; Burlet-Schiltz O; Fiore F; Gonzalez de Peredo A; Malissen M; Roncagalli R; Malissen B
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33125054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CD6 function through interaction with Galectin-1 and -3.
    Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
    FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.
    Singer NG; Mitra R; Lialios F; Richardson BC; Marks RM; Pesando JM; Fox DA; Nickoloff BJ
    Immunol Lett; 1997 Jun; 58(1):9-14. PubMed ID: 9436462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
    Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
    Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.
    Osorio LM; Rottenberg M; Jondal M; Chow SC
    Immunology; 1998 Mar; 93(3):358-65. PubMed ID: 9640246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.
    Castro MA; Oliveira MI; Nunes RJ; Fabre S; Barbosa R; Peixoto A; Brown MH; Parnes JR; Bismuth G; Moreira A; Rocha B; Carmo AM
    J Immunol; 2007 Apr; 178(7):4351-61. PubMed ID: 17371992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain-specific CD6 monoclonal antibodies identify CD6 isoforms generated by alternative-splicing.
    Santos RF; Oliveira L; Brown MH; Carmo AM
    Immunology; 2019 Aug; 157(4):296-303. PubMed ID: 31162836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.
    Osorio LM; Garcia CA; Jondal M; Chow SC
    Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation.
    Breuning J; Brown MH
    Immunology; 2019 Mar; 156(3):270-276. PubMed ID: 30460991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
    J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
    Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
    Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human thymocytes by antibodies to the CD3/T-cell receptor complex: triggering of different epitopes results in different signals.
    Schwinzer R; Sommermeyer H; Schlitt HJ; Schmidt RE; Wonigeit K
    Cell Immunol; 1991 Sep; 136(2):318-28. PubMed ID: 1714794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted effects of soluble human CD6 in experimental cancer models.
    Simões IT; Aranda F; Casadó-Llombart S; Velasco-de Andrés M; Català C; Álvarez P; Consuegra-Fernández M; Orta-Mascaró M; Merino R; Merino J; Alberola-Ila J; González-Aseguinolaza G; Carreras E; Martínez V; Lozano F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.